Factors associated with pathologic complete response following neoadjuvant chemoradiation and esophagectomy for carcinoma of esophagus and gastroesophageal junction-Reference-Cited by-同舟云学术

Factors associated with pathologic complete response following neoadjuvant chemoradiation and esophagectomy for carcinoma of esophagus and gastroesophageal junction

Published:2022-09-21 Issue:1 Volume:127 Page:48-55
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:Journal of Surgical Oncology

Author:

Nusrath Syed¹^ORCID,Thammineedi Subramanyeshwar R.¹^ORCID,Raju Kalidindi Venkata Vijaya Narsimha¹,Patnaik Sujith C.¹,Saksena Ajesh R.¹,Karthik Jaya¹,Basude Madhunarayana¹,Kumar J Pavan¹,Shukla Srijan¹,Rao Vishal B.²,Kumar C Kishore³,Gujjuru Swathi³,Tewani Rohan⁴,Rushdie Tasneem⁵,Sudhir Rashmi⁶,Smith Lynette M.⁷,Are Chandrakanth⁸^ORCID

Affiliation:

1. Department of Surgical Oncology Basavatarakam Indo American Cancer Hospital and Research Institute Hyderabad India

2. Department of Pathology Basavatarakam Indo American Cancer Hospital and Research Institute Hyderabad India

3. Department of Clinical Trials and Research Basavatarakam Indo American Cancer Hospital and Research Institute Hyderabad India

4. Department of Medical Oncology Basavatarakam Indo American Cancer Hospital and Research Institute Hyderabad India

5. Department of Radiation Oncology Basavatarakam Indo American Cancer Hospital and Research Institute Hyderabad India

6. Department of Radiology Basavatarakam Indo American Cancer Hospital and Research Institute Hyderabad India

7. Department of Biostatistics University of Nebraska Medical Center Omaha Nebraska USA

8. Department of Surgery University of Nebraska Medical Center Omaha Nebraska USA

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jso.27103

Reference23 articles.

1. The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

2. Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

3. Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial

4. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis

5. Concurrent neoadjuvant chemoradiotherapy could improve survival outcomes for patients with esophageal cancer: a meta-analysis based on random clinical trials

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nomogram for predicting pathologic complete response to neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma;Cancer Medicine;2024-03

2. The Use of Trimodality Treatment in Patients With Locally Advanced Oesophageal Squamous Cell Carcinoma: An Experience From a Large Cancer Centre in Pakistan;Cureus;2023-10-27